Strategic Decision Making in the Life Sciences Industry: Managing the Build vs. Buy Dilemma

Recording


1.0 CPE Credit

In the field of Specialized Knowledge (SK)

In the competitive landscape of the life sciences industry, strategic decision-making is paramount. Among these decisions, the choice between internal development and manufacturing ('build') versus partnering with Contract Development and Manufacturing Organizations (CDMOs) ('buy') is crucial. This decision can significantly influence a company's path towards innovation, efficiency, and market success, especially in an era where agility, specialized expertise, and cost-effectiveness are key.


Join us for an insightful webcast that not only explores the make vs. buy decision but also delves into the strategic role of CDMOs across the life sciences industry. 
 

Who Should Attend: This webcast is designed for professionals and decision-makers at life sciences companies, including CEOs and CFOs of Biotech and Pharma Companies, Heads of Research and Development, Operations and Manufacturing Directors, Supply Chain and Procurement Managers, and Strategic Planning and Business Development Executives.

Please be advised that photographs and videos will be taken during this event. By registering and attending, you consent to BDO using these images for promotional purposes, including on our website and in marketing materials. You may view the full photography and videography terms and conditions here.

Contact

Stacey Lesanto

mail Email

Technical Support

+1 844-580-6963

BDO Employees

+1 844-580-6963

Share